Amarin Corp Plc\Uk

AMRNNasdaq Ireland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$303.324 M

$14.36 +0.70%

Close of 7 Aug 2026

Revenue

$213.6M

#2274 by revenue

Earnings

-$38.8M

Loss-making

Shares outstanding

420,044,022

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#231Perspective TherapeuticsCATX$342.1M
#232Turn TherapeuticsTTRX$310.1M
#233Amarin Corp Plc\UkAMRN$303.3M
#234Opus GeneticsIRD$302.2M
#235Vanda PharmaceuticalsVNDA$300.7M

Where these numbers come from

Share counts and financials for Amarin Corp Plc\Uk are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.